Icosavax Net Income

Icosavax (ICVX) currently reports a net income of $-93M as of September 2023. That compares with $-85M in the prior-year period — down 9.5% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Icosavax's net income history and peer comparisons.

Icosavax's net income decreased from $-85M to $-93M — a 9.5% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Icosavax's net income of $-93M is lower than the Healthcare sector average of $16B. That is roughly 100.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Icosavax reported $-93M in net income as of September 2023. That compares with $-85M in the prior-year period — down 9.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-93M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Icosavax, and consider following ICVX for alerts when major investors trade the stock.